We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCTY icon
926
Paylocity
PCTY
$7.13B
– –
-2,441
Closed -$389K
PDS
927
Precision Drilling
PDS
$1.03B
– –
-5,762
Closed -$325K
PEBO icon
928
Peoples Bancorp
PEBO
$1.48B
– –
-7,005
Closed -$210K
PFBC icon
929
Preferred Bank
PFBC
$1.25B
– –
-3,044
Closed -$275K
PG icon
930
Procter & Gamble
PG
$354B
– –
-1,803
Closed -$277K
PHAT icon
931
Phathom Pharmaceuticals
PHAT
$954M
– –
-30,968
Closed -$364K
PK icon
932
Park Hotels & Resorts
PK
$3.06B
– –
-17,959
Closed -$199K
PLMR icon
933
Palomar
PLMR
$3.79B
– –
-2,451
Closed -$286K
PLTK icon
934
Playtika
PLTK
$1.5B
– –
-85,073
Closed -$331K
PNFP icon
935
Pinnacle Financial Partners Inc
PNFP
$15.6B
– –
-3,203
Closed -$300K
PNRG icon
936
PrimeEnergy Resources
PNRG
$294M
– –
-1,335
Closed -$223K
PNTG icon
937
Pennant Group
PNTG
$1.44B
– –
-8,811
Closed -$222K
PPC icon
938
Pilgrim's Pride
PPC
$7.13B
– –
-6,351
Closed -$259K
PR
939
Permian Resources
PR
$16.9B
– –
-24,374
Closed -$312K
PRI icon
940
Primerica
PRI
$9.87B
– –
-1,338
Closed -$371K
PRK icon
941
Park National Corp
PRK
$3.58B
– –
-1,305
Closed -$212K
PRTH icon
942
Priority Technology Holdings
PRTH
$535M
– –
-21,006
Closed -$144K
PSO icon
943
Pearson
PSO
$10.2B
– –
-16,583
Closed -$235K
PTC icon
944
PTC
PTC
$14.8B
– –
-1,273
Closed -$258K
HERE
945
Here Group Ltd
HERE
$103M
– –
-18,389
Closed -$166K
QTRX icon
946
Quanterix
QTRX
$172M
– –
-36,144
Closed -$196K
QTWO icon
947
Q2 Holdings
QTWO
$3.67B
– –
-4,007
Closed -$290K
QUAD icon
948
Quad
QUAD
$442M
– –
-20,905
Closed -$131K
RACE icon
949
Ferrari
RACE
$67.4B
– –
-484
Closed -$235K
RAIL icon
950
FreightCar America
RAIL
$279M
– –
-29,447
Closed -$288K
36 37
38
39 40

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.